{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:20:08Z","timestamp":1758050408700,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2010]]},"DOI":"10.3129\/i09-262","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T14:01:10Z","timestamp":1273154470000},"page":"157-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Intravitreal ganciclovir in the management of non-AIDS-related human cytomegalovirus retinitis"],"prefix":"10.1016","volume":"45","author":[{"given":"Beate J.","family":"Langner-Wegscheider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninette","family":"ten Dam-van Loon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Mura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koorosh","family":"Faridpooya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc D.","family":"de Smet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3129\/i09-262_bib1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-93-5-664","article-title":"Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations","volume":"93","author":"Egbert","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.3129\/i09-262_bib2","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4065\/78.11.1412","article-title":"Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus and end-stage renal disease","volume":"78","author":"Shahnaz","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.3129\/i09-262_bib3","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/sj.eye.6701982","article-title":"Management of blinding disease: loss of immunity and superinfection","volume":"19","author":"Evans","year":"2005","journal-title":"Eye"},{"key":"10.3129\/i09-262_bib4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bjo.80.12.1109","article-title":"Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus","volume":"80","author":"Schlingemann","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i09-262_bib5_1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archopht.1986.01050200023017","article-title":"Accelerated cytomegalovirus retinitis secondary to immunosuppressive therapy","volume":"104","author":"Scott","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-262_bib5_2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archopht.1986.01050200023017","article-title":"Accelerated cyto-megalovirus retinitis secondary to immunosuppressive therapy","volume":"104","author":"Scott","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.3129\/i09-262_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/art.1780300116","article-title":"Cytomegalovirus retinitis in rheumatic disease: a case report","volume":"30","author":"Winkler","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.3129\/i09-262_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajo.2004.04.015","article-title":"Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection","volume":"138","author":"Kuo","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i09-262_bib8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa011759","article-title":"A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis","volume":"346","author":"Martin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3129\/i09-262_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"Biron","year":"2006","journal-title":"Antiviral Res"},{"key":"10.3129\/i09-262_bib10","first-page":"1250","article-title":"4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group","volume":"101","year":"1994","journal-title":"Ophthalmology"},{"key":"10.3129\/i09-262_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9394(01)01322-8","article-title":"Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"133","author":"Jabs","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i09-262_bib12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.3129\/i09-262_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/bjo.87.1.122","article-title":"Visual symptoms in patients on cyclophosphamide may herald sight threatening disease","volume":"87","author":"Agrawal","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.3129\/i09-262_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00042560-200208010-00004","article-title":"A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis","volume":"30","author":"Lalezari","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.3129\/i09-262_bib15","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.transproceed.2009.02.093","article-title":"Severe bone marrow failure due to valganciclovir overdose after renal transplantation from cadaveric donors: four consecutive cases","volume":"41","author":"Ar","year":"2009","journal-title":"Transplant Proc"},{"key":"10.3129\/i09-262_bib16","first-page":"778","article-title":"Longterm effects of cyclophosphamide on granulocyte colony formation in patients with rheumatoid arthritis","volume":"10","author":"Thomas","year":"1983","journal-title":"J Rheumatol"},{"key":"10.3129\/i09-262_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0420.2005.00410.x","article-title":"Cytomegalovirus retinitis in Wegener's granulomatosis: case report and review of the literature","volume":"83","author":"Bertelmann","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.3129\/i09-262_bib18","first-page":"300","article-title":"Treatment of CMV retinitis with intravitreal ganciclovir in the HAART era","volume":"12","author":"Campbell","year":"2001","journal-title":"Can J Infect Dis"},{"key":"10.3129\/i09-262_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9394(14)72168-3","article-title":"Local therapy for cytomegalovirus retinopathy","volume":"120","author":"Engstrom","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.3129\/i09-262_bib20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/eye.1997.147","article-title":"Cytomegalovirus retinitis in the presence of a normal helper T-cell count","volume":"11","author":"Morrison","year":"1997","journal-title":"Eye"},{"key":"10.3129\/i09-262_bib21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4049\/jimmunol.173.3.1834","article-title":"Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection","volume":"173","author":"van Leeuwen","year":"2004","journal-title":"J Immunol"},{"key":"10.3129\/i09-262_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1084\/jem.179.1.185","article-title":"The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease","volume":"179","author":"Reddehase","year":"1994","journal-title":"J Exp Med"},{"key":"10.3129\/i09-262_bib23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1086\/591185","article-title":"Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"198","author":"Moins-Teisserenc","year":"2008","journal-title":"J Infect Dis"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000841821080078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000841821080078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:01:13Z","timestamp":1757793673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000841821080078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"alternative-id":["S000841821080078X"],"URL":"https:\/\/doi.org\/10.3129\/i09-262","relation":{},"ISSN":["0008-4182"],"issn-type":[{"type":"print","value":"0008-4182"}],"subject":[],"published":{"date-parts":[[2010]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal ganciclovir in the management of non-AIDS-related human cytomegalovirus retinitis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3129\/i09-262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}